CIK 0000885725
- Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042695240
- Phone
- +1 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-17 | Pierce David A EVP Pres MedSurg | Exercise or conversion · Restricted Stock Units | −3,333 | 10,000 | ||
| 2022-02-17 | Olson Scott SVP & Pres, CRM, Diagnostics | Exercise or conversion | +1,416 | 14,260 | ||
| 2022-02-17 | Olson Scott SVP & Pres, CRM, Diagnostics | Shares withheld for taxes | −713 | $42.83 | $31K | 13,547 |
| 2022-02-17 | Olson Scott SVP & Pres, CRM, Diagnostics | Exercise or conversion · Restricted Stock Units | −1,416 | 4,250 | ||
| 2022-02-17 | Nanavaty Maulik SVP & Pres, Neuromodulation | Exercise or conversion | +2,166 | 174,658 | ||
| 2022-02-17 | Nanavaty Maulik SVP & Pres, Neuromodulation | Shares withheld for taxes | −750 | $42.83 | $32K | 173,908 |
| 2022-02-17 | Nanavaty Maulik SVP & Pres, Neuromodulation | Exercise or conversion · Restricted Stock Units | −2,166 | 6,500 | ||
| 2022-02-17 | Monson Jonathan VP, Global Controller and CAO | Exercise or conversion | +1,000 | 30,222 | ||
| 2022-02-17 | Monson Jonathan VP, Global Controller and CAO | Shares withheld for taxes | −350 | $42.83 | $15K | 29,872 |
| 2022-02-17 | Monson Jonathan VP, Global Controller and CAO | Exercise or conversion · Restricted Stock Units | −1,000 | 3,000 | ||
| 2022-02-17 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Exercise or conversion | +3,333 | 137,894 | ||
| 2022-02-17 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Shares withheld for taxes | −1,020 | $42.83 | $44K | 136,874 |
| 2022-02-17 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Exercise or conversion · Restricted Stock Units | −3,333 | 10,000 | ||
| 2022-02-17 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion | +1,250 | 32,871 | ||
| 2022-02-17 | Meredith Ian T EVP Global Chief Med Officer | Shares withheld for taxes | −367 | $42.83 | $16K | 32,504 |
| 2022-02-17 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion · Restricted Stock Units | −1,250 | 3,750 | ||
| 2022-02-17 | Mahoney Michael F Chairman, President & CEO | Exercise or conversion | +18,333 | 2,112,616 | ||
| 2022-02-17 | Mahoney Michael F Chairman, President & CEO | Shares withheld for taxes | −8,131 | $42.83 | $348K | 2,104,485 |
| 2022-02-17 | Mahoney Michael F Chairman, President & CEO | Exercise or conversion · Restricted Stock Units | −18,333 | 55,000 | ||
| 2022-02-17 | Mackey Edward F EVP, Operations | Exercise or conversion | +2,833 | 35,267 |
Page 78 of 87 · 1,736 trades